Jan 14, 2021 7:10am EST Mydecine Innovations Group Announces C$10 Million Bought Deal Offering of Units
Jan 11, 2021 7:30am EST Mydecine Innovations Group Appoints Gordon Neal to Board of Directors and Dean Ditto as Chief Financial Officer
Jan 05, 2021 7:30am EST Mydecine Innovations Group Sponsors First Lab-Based Study of Established Microdosers at Macquarie University in Australia
Dec 21, 2020 7:30am EST Mydecine Innovations Group Engages ethica CRO as Contract Research Organization Partner for Phase 2A PTSD Clinical Trials
Dec 15, 2020 7:30am EST Mydecine Innovations Group Engages the ProPharma Group to Proceed with FDA Filings and Approval for Novel Research and Multiple Phase Clinical Trials
Dec 10, 2020 7:30am EST Mydecine Innovations Group Partners with Microdose Psychedelic Insights to Present a Free, Live Webinar Series on The Renaissance of Psychedelics
Dec 08, 2020 7:30am EST Mydecine Innovations Group to Make First Commercial Export of Legal Psilocybin Mushrooms